http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GE-P20002210-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbb7b2364a16bd1d7bb2c345db7952c7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1992-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55040031cef0b2af399835908a73ec6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d295427fbbf7e2186c1b073744cecdba
publicationDate 2000-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GE-P20002210-B
titleOfInvention Acridine Derivatives
abstract 1. Technical Result Increase in stability of polyresistent cells to chemotherapeutic agents and reduce of toxicity. 2. Essence Compounds of general formula (1) (the value of R0, R1, R2, R3, R4, R5, R6, R7, R8 , p and m are disclosed in the description), a method for their production and pharmaceutical composition on their basis. 3. Field of Application Medicine.
priorityDate 1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456373159

Total number of triples: 31.